Vita 34 AG logo

Vita 34 AG Investor Relations Material

Vita 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company also manufactures and sells reagents for bone marrow diagnostics. Its products include frozen cord blood units, partal bio-banking, culture and expansion f IMR90 K1, hematopoietic stem cells, adult progenitor cells, endothelial progenitor cells Mitomycin C; Vitapur; Vitafrost; Vitastem ampoules; sweet-hand sterilization bags for various applications; freezing bag for ten freezing bags; and pipette with tips. The company was founded in 1997 and is headquartered in Leipzig, Germany

Upcoming events for

Q3 20222022-11-22
Q2 20222022-08-30

Latest company events

Ticker symbol




Investor Relations Page

Dig deeper into the Vita 34 AG fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot